speb/financial-data huggingface dataset:
Financial ratios for CHCT — quarterly report dated 2025-09-30
Total revenue: 31086000
Gross profit: 25156000
Operating income: 9596000
Net income: 1640000
Capital expenditures: 5076000
Operating cash flow: 12722000
Depreciation & amortization: 11263000
Net tangible assets: 425340000
Owner earnings: 7827000
Return on net tangible assets (%): 1.8401749188884189
Capex to operating income (%): 52.897040433513965
Buffett classification: The Good
Stock price: 14
P/E ratio: 60.9763875
Shares outstanding: 28571793
Book value: 426823000
P/B ratio: 0.9371685733899063
Market cap (USD): 400005102
Debt to equity: 1.251434435351422
Current ratio: 0.17422426637299993
Quick ratio: 0.17422426637299993
Interest coverage ratio: 1.3563250883392226
COGS to revenue (%): 19.07611143279933
SG&A to revenue (%): 14.984237277230909
Free cash flow (dilution-adjusted): 5181000
Buyback yield (%): 0
Retained earnings: 76349000
Receivables turnover: 0.8483244187315795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.352701950253385
FCF margin (%): 16.666666666666664
Revenue growth (%): 6.879834966477566
Rule of 40 score: 23.54650163314423
Financial ratios for CHCT — annual report dated 2025-12-31
Total revenue: 121195000
Gross profit: 97571000
Operating income: 20266000
Net income: 5102000
Capital expenditures: 20524000
Operating cash flow: 56430000
Depreciation & amortization: 44868000
Net tangible assets: 428080000
Owner earnings: 29446000
Return on net tangible assets (%): 6.87862081853859
Capex to operating income (%): 101.27306819303266
Buffett classification: The Gruesome
Stock price: 15.52
P/E ratio: 86.91380387299098
Shares outstanding: 28571793
Book value: 429387000
P/B ratio: 1.032714607941088
Market cap (USD): 443434227.36
Debt to equity: 1.2487453043524839
Current ratio: 0.17008951136188472
Quick ratio: 0.17008951136188472
Effective tax rate (%): 0.448780487804878
Interest coverage ratio: 0.7512046852991326
COGS to revenue (%): 19.492553323156898
SG&A to revenue (%): 20.706299764841784
Free cash flow (dilution-adjusted): 21010000
Buyback yield (%): 0
Retained earnings: 90777000
Receivables turnover: 3.249544187044187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8471560751786322
FCF margin (%): 17.335698667436773
Revenue growth (%): 4.671549237386213
Rule of 40 score: 22.007247904822986
Financial ratios for CHCT — quarterly report dated 2025-12-31
Total revenue: 30946000
Gross profit: 24932000
Operating income: 3440000
Net income: 14428000
Capital expenditures: 6537000
Operating cash flow: 15500000
Depreciation & amortization: 11239000
Net tangible assets: 428080000
Owner earnings: 19130000
Return on net tangible assets (%): 4.468790880209307
Capex to operating income (%): 190.02906976744185
Buffett classification: The Gruesome
Stock price: 15.52
P/E ratio: 86.91380387299098
Shares outstanding: 28571793
Book value: 429387000
P/B ratio: 1.032714607941088
Market cap (USD): 443434227.36
Debt to equity: 1.2487453043524839
Current ratio: 0.17008951136188472
Quick ratio: 0.17008951136188472
Interest coverage ratio: 0.494323897111654
COGS to revenue (%): 19.43385251728818
SG&A to revenue (%): 34.50526723970788
Free cash flow (dilution-adjusted): 6364000
Buyback yield (%): 0
Retained earnings: 90777000
Receivables turnover: 0.8297404547404548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.48328317865461834
FCF margin (%): 20.56485490855038
Revenue growth (%): -0.45036350768834843
Rule of 40 score: 20.114491400862033
Financial ratios for CLGN — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 249354.83870967742
Buffett classification: The Gruesome
Stock price: 16.36
Shares outstanding: 18908207
Market cap (USD): 309338266.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLGN — annual report dated 2022-12-31
Total revenue: 84943.18181818182
Gross profit: -28693.18181818182
Operating income: -4857102.2727272725
Net income: -4808238.636363637
Capital expenditures: 361931.8181818182
Operating cash flow: -3891477.272727273
Depreciation & amortization: 305681.8181818182
Net tangible assets: 9101136.363636363
Owner earnings: -4864488.636363637
Return on net tangible assets (%): -53.44924459982521
Buffett classification: The Gruesome
Stock price: 8.35
Shares outstanding: 18908207
Book value: 9170738.636363637
P/B ratio: 17.216010041324616
Market cap (USD): 157883528.45
Debt to equity: 0.09017688423530869
Current ratio: 10.195813204508857
Quick ratio: 9.735265700483092
COGS to revenue (%): 133.7792642140468
R&D to revenue (%): 3429.7658862876256
SG&A to revenue (%): 2254.5150501672238
Free cash flow (dilution-adjusted): -4882954.545454546
Buyback yield (%): 0
Retained earnings: -25489204.545454547
Inventory turnover: 0.2797202797202797
Receivables turnover: 0.5416666666666666
Capitalized R&D asset: 2913352.272727273
ROCI (R&D-adjusted, %): -22.84236460513231
FCF margin (%): -5748.494983277592
Rule of 40 score: -5748.494983277592
Financial ratios for CLGN — annual report dated 2023-12-31
Total revenue: 504894.6077348066
Gross profit: -45105.39226519337
Operating income: -4597591.580110497
Net income: -1938950.276243094
Capital expenditures: 244751.3812154696
Operating cash flow: -763259.6685082873
Depreciation & amortization: 304419.8895027624
Net tangible assets: 7776795.580110497
Owner earnings: -1879281.7679558012
Return on net tangible assets (%): -24.165245808468317
Buffett classification: The Gruesome
Stock price: 6.39
Shares outstanding: 18908207
Book value: 7828729.281767957
P/B ratio: 15.433340249915311
Market cap (USD): 120823442.72999999
Debt to equity: 0.11146788990825686
Current ratio: 8.619501691787143
Quick ratio: 8.399876960935098
COGS to revenue (%): 108.93362527034252
R&D to revenue (%): 573.6113145827578
SG&A to revenue (%): 328.0592752993339
Free cash flow (dilution-adjusted): -1561878.4530386738
Buyback yield (%): 0
Retained earnings: -26724033.14917127
Inventory turnover: 2.7885154061624653
Receivables turnover: 4.650683155216285
Capitalized R&D asset: 4848078.619412355
ROCI (R&D-adjusted, %): -27.195417930097605
Rosenberg metric: -0.005633445224132681
FCF margin (%): -309.34742203843115
Revenue growth (%): 494.39097632993946
Rule of 40 score: 185.04355429150831
Financial ratios for CLGN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.97
Shares outstanding: 18908207
Market cap (USD): 93973788.78999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLGN — quarterly report dated 2024-12-31
Total revenue: 44931.50684931507
Gross profit: -29589.04109589041
Operating income: -1088767.1232876712
Net income: -1062465.7534246575
Capital expenditures: 15890.41095890411
Operating cash flow: -949041.095890411
Depreciation & amortization: 66301.3698630137
Net tangible assets: 3653150.684931507
Owner earnings: -1012054.7945205478
Return on net tangible assets (%): -27.70361481925903
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 18908207
Book value: 3689041.0958904107
P/B ratio: 18.451826214630525
Market cap (USD): 68069545.2
Debt to equity: 0.2288154474563684
Current ratio: 4.437710437710439
Quick ratio: 4.28956228956229
COGS to revenue (%): 165.85365853658539
R&D to revenue (%): 1550.6097560975609
SG&A to revenue (%): 806.7073170731709
Free cash flow (dilution-adjusted): -1081369.8630136987
Buyback yield (%): 0
Retained earnings: -31054794.520547945
Inventory turnover: 0.6181818181818183
Receivables turnover: 0.28130360205831906
Capitalized R&D asset: 696712.3287671233
ROCI (R&D-adjusted, %): -12.463308355667378
FCF margin (%): -2406.707317073171
Rule of 40 score: -2406.707317073171
Financial ratios for CLGN — annual report dated 2024-12-31
Total revenue: 141095.8904109589
Gross profit: -304109.5890410959
Operating income: -4726301.369863014
Net income: -4550410.95890411
Capital expenditures: 132054.79452054796
Operating cash flow: -3861095.890410959
Depreciation & amortization: 284383.5616438356
Net tangible assets: 3653150.684931507
Owner earnings: -4398082.191780822
Return on net tangible assets (%): -120.39148042597871
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 18908207
Book value: 3689041.0958904107
P/B ratio: 18.451826214630525
Market cap (USD): 68069545.2
Debt to equity: 0.2288154474563684
Current ratio: 4.437710437710439
Quick ratio: 4.28956228956229
COGS to revenue (%): 315.5339805825243
R&D to revenue (%): 2041.747572815534
SG&A to revenue (%): 1092.4271844660195
Free cash flow (dilution-adjusted): -4464383.561643836
Buyback yield (%): 0
Retained earnings: -31054794.520547945
Inventory turnover: 3.6931818181818183
Receivables turnover: 0.8833619210977701
Capitalized R&D asset: 5782637.007587224
ROCI (R&D-adjusted, %): -46.976369082978
Rosenberg metric: -0.08943105611682252
FCF margin (%): -3164.077669902913
Revenue growth (%): -72.05438753961324
Rule of 40 score: -3236.1320574425263
Financial ratios for CLGN — quarterly report dated 2025-03-31
Total revenue: 20867.208672086723
Gross profit: -30081.30081300813
Operating income: -982655.8265582656
Net income: -393495.9349593496
Capital expenditures: 2168.021680216802
Operating cash flow: -316260.162601626
Depreciation & amortization: 66124.66124661246
Net tangible assets: 3328184.2818428185
Owner earnings: -329539.29539295397
Return on net tangible assets (%): -9.901473821350054
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 18908207
Book value: 3359620.596205962
P/B ratio: 14.520441419811245
Market cap (USD): 48783174.06
Debt to equity: 0.2293296765346455
Current ratio: 4.478888888888888
Quick ratio: 4.229629629629629
COGS to revenue (%): 244.15584415584414
R&D to revenue (%): 2733.7662337662337
SG&A to revenue (%): 1831.168831168831
Free cash flow (dilution-adjusted): -422222.22222222225
Buyback yield (%): 0
Retained earnings: -31111653.116531167
Inventory turnover: 0.27934621099554235
Receivables turnover: 0.17500000000000002
Capitalized R&D asset: 1037257.9648810187
ROCI (R&D-adjusted, %): -16.79597432702765
Rosenberg metric: -0.0007065465857175276
FCF margin (%): -2023.3766233766232
Revenue growth (%): -53.557736796880164
Rule of 40 score: -2076.9343601735036
Financial ratios for CLGN — quarterly report dated 2025-06-30
Total revenue: 52802.3598820059
Gross profit: -2064.896755162242
Operating income: -937463.1268436578
Net income: -987315.634218289
Capital expenditures: 884.9557522123894
Operating cash flow: -719764.01179941
Depreciation & amortization: 67551.62241887905
Net tangible assets: 3658702.064896755
Owner earnings: -920648.9675516224
Return on net tangible assets (%): -25.16326695154398
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 18908207
Book value: 3688790.560471976
P/B ratio: 6.971163338888446
Market cap (USD): 25715161.520000003
Debt to equity: 0.24206317473010797
Current ratio: 4.6039387308533914
Quick ratio: 4.402261123267687
COGS to revenue (%): 103.91061452513965
R&D to revenue (%): 1124.5810055865923
SG&A to revenue (%): 646.9273743016761
Free cash flow (dilution-adjusted): -824778.7610619469
Buyback yield (%): 0
Retained earnings: -34852212.38938053
Inventory turnover: 0.33634719710669075
Receivables turnover: 0.4917582417582418
Capitalized R&D asset: 1205929.0503143847
ROCI (R&D-adjusted, %): -17.39811648814405
Rosenberg metric: 0.049111891198789226
FCF margin (%): -1562.0111731843576
Revenue growth (%): 153.03988047350876
Rule of 40 score: -1408.971292710849
Financial ratios for CLGN — quarterly report dated 2025-09-30
Total revenue: 23262.83987915408
Gross profit: -58006.042296072505
Operating income: -1059516.6163141993
Net income: -1052265.8610271902
Capital expenditures: 302.11480362537765
Operating cash flow: -869184.2900302114
Depreciation & amortization: 67371.60120845921
Net tangible assets: 2784592.1450151056
Owner earnings: -985196.3746223564
Return on net tangible assets (%): -35.38027557773679
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 18908207
Book value: 2811178.2477341387
P/B ratio: 18.09315253168189
Market cap (USD): 50863076.83
Debt to equity: 0.3159591617409995
Current ratio: 3.655775075987842
Quick ratio: 3.4506079027355625
COGS to revenue (%): 349.3506493506493
R&D to revenue (%): 2712.9870129870133
SG&A to revenue (%): 1592.2077922077922
Free cash flow (dilution-adjusted): -954682.7794561933
Buyback yield (%): 0
Retained earnings: -36746827.79456193
Inventory turnover: 0.4981481481481481
Receivables turnover: 0.3031496062992126
Capitalized R&D asset: 1217219.4148158631
ROCI (R&D-adjusted, %): -21.948260725953336
Rosenberg metric: -0.0942078904042155
FCF margin (%): -4103.896103896104
Revenue growth (%): -55.94356022886462
Rule of 40 score: -4159.839664124969
Financial ratios for CLGN — quarterly report dated 2025-12-31
Total revenue: 18867.924528301886
Gross profit: -41509.43396226415
Operating income: -990566.037735849
Net income: -1008490.5660377358
Capital expenditures: 4716.981132075472
Operating cash flow: -922955.9748427672
Depreciation & amortization: 67924.52830188679
Net tangible assets: 1889308.176100629
Owner earnings: -945283.0188679245
Return on net tangible assets (%): -50.03328894806924
Buffett classification: The Gruesome
Stock price: 1.4
Shares outstanding: 18908207
Book value: 1912264.1509433961
P/B ratio: 13.843008972866306
Market cap (USD): 26471489.799999997
Debt to equity: 0.46801512909061005
Current ratio: 2.525074850299401
Quick ratio: 2.3106287425149703
COGS to revenue (%): 320
R&D to revenue (%): 3300
SG&A to revenue (%): 1730
Free cash flow (dilution-adjusted): -922012.5786163522
Buyback yield (%): 0
Retained earnings: -39257547.169811316
Inventory turnover: 0.3350785340314136
Receivables turnover: 0.2678571428571429
Capitalized R&D asset: 1241446.2042445391
ROCI (R&D-adjusted, %): -25.93873375110408
Rosenberg metric: 0.026138714018624054
FCF margin (%): -4886.666666666667
Revenue growth (%): -18.892428326390593
Rule of 40 score: -4905.559094993057
Financial ratios for CLGN — annual report dated 2025-12-31
Total revenue: 745597.4842767295
Gross profit: 483018.86792452825
Operating income: -3611006.289308176
Net income: -3612893.0817610063
Capital expenditures: 8490.566037735849
Operating cash flow: -2961949.685534591
Depreciation & amortization: 286792.4528301887
Net tangible assets: 1889308.176100629
Owner earnings: -3334591.1949685533
Return on net tangible assets (%): -176.49800266311584
Buffett classification: The Gruesome
Stock price: 1.4
Shares outstanding: 18908207
Book value: 1912264.1509433961
P/B ratio: 13.843008972866306
Market cap (USD): 26471489.799999997
Debt to equity: 0.46801512909061005
Current ratio: 2.525074850299401
Quick ratio: 2.3106287425149703
COGS to revenue (%): 35.217207929143825
R&D to revenue (%): 345.29734289329394
SG&A to revenue (%): 203.7958667229017
Free cash flow (dilution-adjusted): -3284905.6603773586
Buyback yield (%): 0
Retained earnings: -39257547.169811316
Inventory turnover: 1.4572425828970332
Receivables turnover: 10.584821428571429
Capitalized R&D asset: 5460402.743724377
ROCI (R&D-adjusted, %): -47.684316411577996
Rosenberg metric: 0.27323051525673114
FCF margin (%): -440.57359763812747
Revenue growth (%): 428.4331684679733
Rule of 40 score: -12.140429170154164
Financial ratios for CLSEL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2588685216932611
Shares outstanding: 49725620
Market cap (USD): 62598017.73968086
Buyback yield (%): 0
Retained earnings: 45351153.89687459
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLSEL.NS — annual report dated 2023-03-31
Total revenue: 168982509.13520098
Gross profit: 37313495.736906216
Operating income: 18775992.691839222
Net income: 14332265.529841658
Capital expenditures: 1103215.5907429964
Operating cash flow: 874445.7978075518
Depreciation & amortization: 715749.0864799026
Net tangible assets: 74103836.78440925
Owner earnings: 13944799.025578564
Return on net tangible assets (%): 18.817917709373475
Capex to operating income (%): 5.8756711767495355
Buffett classification: The Great
Stock price: 2.044336175395859
P/E ratio: 7.092799362272974
Shares outstanding: 49725620
Book value: 74111668.69671133
P/B ratio: 1.3716582772680002
Market cap (USD): 101655883.80998784
Debt to equity: 0.19818399597144776
Current ratio: 4.266221296365831
Quick ratio: 1.6507943019022482
Effective tax rate (%): 25.147836773952225
Interest coverage ratio: 24.24061202667002
COGS to revenue (%): 77.91872311053677
SG&A to revenue (%): 9.098859520592695
Free cash flow (dilution-adjusted): -228769.7929354446
Buyback yield (%): 0
Retained earnings: 54960730.816077955
Inventory turnover: 2.608343348849038
Receivables turnover: 9.012646386454392
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.373411841660957
FCF margin (%): -0.13538075278099257
Rule of 40 score: -0.13538075278099257
Financial ratios for CLSEL.NS — annual report dated 2024-03-31
Total revenue: 162564863.89255306
Gross profit: 30494112.00383739
Operating income: 18566650.677539274
Net income: 13866926.489986809
Capital expenditures: 1642379.182156134
Operating cash flow: -4582252.068593357
Depreciation & amortization: 847439.7409761362
Net tangible assets: 85606019.90646361
Owner earnings: 13071987.04880681
Return on net tangible assets (%): 15.26993903359806
Capex to operating income (%): 8.845855995680349
Buffett classification: The Great
Stock price: 2.397552783109405
P/E ratio: 8.597420539362368
Shares outstanding: 49725620
Book value: 85617735.9395611
P/B ratio: 1.3924661440124952
Market cap (USD): 119219798.62284069
Debt to equity: 0.2451471449002565
Current ratio: 3.7999396197391335
Quick ratio: 1.5561475776239018
Effective tax rate (%): 25.16839913880076
Interest coverage ratio: 15.693493619307299
COGS to revenue (%): 77.59273116438104
SG&A to revenue (%): 6.6602617649497455
Free cash flow (dilution-adjusted): -6224631.25074949
Buyback yield (%): 0
Retained earnings: 65376364.072430745
Inventory turnover: 2.1060797394543256
Receivables turnover: 6.790527922931427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.06010232216933
FCF margin (%): -3.8290139097115405
Revenue growth (%): -3.7978162802123094
Rule of 40 score: -7.62683018992385
Financial ratios for CLSEL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 80659902.05446728
Buffett classification: The Gruesome
Stock price: 3.58707596751075
Shares outstanding: 49725620
Book value: 80676313.90348783
P/B ratio: 2.21092868329301
Market cap (USD): 178369576.47157192
Debt to equity: 0.07039538682551251
Current ratio: 4.7492871993944386
Quick ratio: 3.5757360901302966
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLSEL.NS — quarterly report dated 2025-03-31
Total revenue: 42984650.45592705
Gross profit: 9864601.356090717
Operating income: 4037596.446107084
Net income: 2870201.0755202244
Capital expenditures: 0
Depreciation & amortization: -136766.4250642974
Net tangible assets: 85702992.75192891
Owner earnings: 2733434.650455927
Return on net tangible assets (%): 3.189427303160782
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.6010036176916795
P/E ratio: 15.596654450377374
Shares outstanding: 49725620
Book value: 85722702.8290858
P/B ratio: 2.0888531462776716
Market cap (USD): 179062137.51196173
Debt to equity: 0.16796332056862937
Current ratio: 4.696786003363633
Quick ratio: 2.1673501235120813
Effective tax rate (%): 22.584032288579177
Interest coverage ratio: 7.355154716016781
COGS to revenue (%): 77.05087455298705
Buyback yield (%): 0
Retained earnings: 65993640.40215103
Inventory turnover: 0.6531606750144726
Receivables turnover: 1.6093785768216486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.337268541541714
Rule of 40 score: 0
Financial ratios for CLSEL.NS — annual report dated 2025-03-31
Total revenue: 174801940.6125789
Gross profit: 38359457.56371288
Operating income: 16070014.028524665
Net income: 12027075.052606966
Capital expenditures: 2030815.99251812
Operating cash flow: 8497030.628945522
Depreciation & amortization: 422153.37853635725
Net tangible assets: 85702992.75192891
Owner earnings: 10418412.438625203
Return on net tangible assets (%): 12.156416134477075
Capex to operating income (%): 12.637300682584174
Buffett classification: The Great
Stock price: 3.6010036176916795
P/E ratio: 14.888253106323516
Shares outstanding: 49725620
Book value: 85722702.8290858
P/B ratio: 2.0888531462776716
Market cap (USD): 179062137.51196173
Debt to equity: 0.16796332056862937
Current ratio: 4.696786003363633
Quick ratio: 2.1673501235120813
Effective tax rate (%): 24.55742948680813
Interest coverage ratio: 14.062988501043499
COGS to revenue (%): 78.05547385270131
SG&A to revenue (%): 0.4391623159060811
Free cash flow (dilution-adjusted): 6466214.636427402
Buyback yield (%): 0
Retained earnings: 65993640.40215103
Inventory turnover: 2.690782977410757
Receivables turnover: 6.544719927341963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.262737184954783
FCF margin (%): 3.699166390125355
Revenue growth (%): 7.527504054082628
Rule of 40 score: 11.226670444207983
Financial ratios for CLSEL.NS — quarterly report dated 2025-06-30
Total revenue: 35954282.705359235
Gross profit: 8929780.014041658
Operating income: 3320032.7638661363
Net income: 2532740.4633746785
Capital expenditures: 0
Depreciation & amortization: 123192.13667212732
Owner earnings: 2655932.600046806
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.427685466885093
P/E ratio: 21.732329880386974
Shares outstanding: 49725620
Market cap (USD): 220169405.0058507
Effective tax rate (%): 24.724474075001478
Interest coverage ratio: 15.283059520603285
COGS to revenue (%): 75.16351504709448
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -16.3555308139034
Rule of 40 score: -16.3555308139034
Financial ratios for CLSEL.NS — quarterly report dated 2025-09-30
Total revenue: 30772762.119503945
Gross profit: 6318399.098083427
Operating income: 2611939.1206313414
Net income: 2134013.5287485905
Capital expenditures: 0
Depreciation & amortization: 123156.70800450958
Net tangible assets: 85677249.1544532
Owner earnings: 2257170.2367531
Return on net tangible assets (%): 2.6345036273095377
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.956031567080045
P/E ratio: 19.50263748336036
Shares outstanding: 49725620
Book value: 85698658.39909807
P/B ratio: 1.7152019081569871
Market cap (USD): 146990502.41262683
Debt to equity: 0.08803888089555299
Current ratio: 3.845851533175189
Quick ratio: 2.818476522382884
Effective tax rate (%): 24.65259395189058
Interest coverage ratio: 12.338445971134899
COGS to revenue (%): 79.46755941651791
Buyback yield (%): 0
Inventory turnover: 1.0071093282074852
Receivables turnover: 1.6933968204730516
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.038324654678906
Revenue growth (%): -14.411414151457812
Rule of 40 score: -14.411414151457812
Financial ratios for CLSEL.NS — quarterly report dated 2025-12-31
Total revenue: 48010214.99387323
Gross profit: 10631458.170881141
Operating income: 5548735.657792136
Net income: 4003575.8048345773
Capital expenditures: 0
Depreciation & amortization: 140781.99844045896
Owner earnings: 4144357.803275036
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.9414058148601985
P/E ratio: 12.673873449300155
Shares outstanding: 49725620
Market cap (USD): 146263227.81552857
Effective tax rate (%): 25.703376621228845
Interest coverage ratio: 23.712748738455684
COGS to revenue (%): 77.85584136159804
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 56.01529302903913
Rule of 40 score: 56.01529302903913
Financial ratios for CODE.OL — annual report dated 2021-12-31
Capital expenditures: 12632046.59090909
Buffett classification: The Gruesome
Stock price: 3.1790193842645382
Shares outstanding: 19754924
Market cap (USD): 62801286.33067275
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CODE.OL — annual report dated 2022-12-31
Total revenue: 19737414.068825908
Gross profit: 16469139.574898785
Operating income: -15101212.651821861
Net income: -15646638.157894736
Capital expenditures: 8106896.356275303
Operating cash flow: -11149409.51417004
Depreciation & amortization: 12235478.846153846
Net tangible assets: -18534455.36437247
Owner earnings: -11518055.668016193
Buffett classification: The Gruesome
Stock price: 1.1336032388663966
Shares outstanding: 19754924
Book value: 60670114.77732793
P/B ratio: 0.36911494089225144
Market cap (USD): 22394245.82995951
Debt to equity: 0.362835575520816
Current ratio: 1.8429387807065587
Quick ratio: 1.8429387807065587
Interest coverage ratio: -4.449748583208222
COGS to revenue (%): 16.55877757101511
R&D to revenue (%): -20.155672822014786
SG&A to revenue (%): 11.049139288789126
Free cash flow (dilution-adjusted): -19490770.445344128
Buyback yield (%): 0
Retained earnings: -60571621.96356275
Receivables turnover: 5.877002749152077
Capitalized R&D asset: -3978208.603238866
ROCI (R&D-adjusted, %): -21.425814766725672
FCF margin (%): -98.75037518784521
Rule of 40 score: -98.75037518784521
Financial ratios for CODE.OL — annual report dated 2023-12-31
Total revenue: 5812521.709233792
Gross profit: 4952310.707269155
Operating income: -10961041.55206287
Net income: 2951080.550098232
Capital expenditures: 3664590.4715127703
Operating cash flow: -5829004.42043222
Depreciation & amortization: 4164470.6286836937
Net tangible assets: 7021369.351669941
Owner earnings: 3450960.7072691554
Return on net tangible assets (%): 49.149397139297186
Buffett classification: The Gruesome
Stock price: 2.4263261296660117
P/E ratio: 16.24214841888023
Shares outstanding: 19754924
Book value: 13119157.956777997
P/B ratio: 3.6535796313057007
Market cap (USD): 47931888.29076621
Debt to equity: 0
Current ratio: 13.733156982814398
Quick ratio: 13.733156982814398
Effective tax rate (%): -10.076793604656276
Interest coverage ratio: -5.178994910184449
COGS to revenue (%): 14.799273791925843
R&D to revenue (%): -27.400779000407137
SG&A to revenue (%): 16.573426068789132
Free cash flow (dilution-adjusted): -9662702.259332024
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 182.60658009245827
Capitalized R&D asset: -4258075.992067879
ROCI (R&D-adjusted, %): -120.71613933378251
FCF margin (%): -166.23941797897842
Revenue growth (%): -70.55074343090197
Rule of 40 score: -236.7901614098804
Financial ratios for CODE.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1580418.7113857018
Buffett classification: The Gruesome
Stock price: 0.22751322751322753
Shares outstanding: 19754924
Book value: 1580418.7113857018
P/B ratio: 2.843870732571726
Market cap (USD): 4494506.518518519
Debt to equity: 0
Current ratio: 7.50364146334858
Quick ratio: 7.50364146334858
Buyback yield (%): 0
Retained earnings: -2563360.5472197705
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CODE.OL — annual report dated 2024-12-31
Total revenue: 22011.297440423656
Gross profit: -142367.519858782
Operating income: -12025579.876434246
Net income: -13317254.6337158
Capital expenditures: 1171457.4580759048
Operating cash flow: -4977396.469549867
Depreciation & amortization: 7028097.263901147
Net tangible assets: 1580418.7113857018
Owner earnings: -7460614.827890556
Return on net tangible assets (%): -472.0657110766003
Buffett classification: The Gruesome
Stock price: 0.22751322751322753
Shares outstanding: 19754924
Book value: 1580418.7113857018
P/B ratio: 2.843870732571726
Market cap (USD): 4494506.518518519
Debt to equity: 0
Current ratio: 7.50364146334858
Quick ratio: 7.50364146334858
Interest coverage ratio: -2034.3081103678933
COGS to revenue (%): 746.7929491394933
R&D to revenue (%): -3282.536850209312
SG&A to revenue (%): 1932.6050170818164
Free cash flow (dilution-adjusted): -6143362.40070609
Buyback yield (%): 0
Retained earnings: -2563360.5472197705
Receivables turnover: 7.893024433472592
Capitalized R&D asset: -3102430.861451464
FCF margin (%): -27910.04218326463
Revenue growth (%): -99.62131242614619
Rule of 40 score: -28009.663495690776
Financial ratios for CODE.OL — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2405900.2979145977
Buffett classification: The Gruesome
Stock price: 0.28798411122144985
Shares outstanding: 19754924
Book value: 2594579.5431976165
P/B ratio: 2.192688308709901
Market cap (USD): 5689104.230387289
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -259102.78053624628
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.41
Shares outstanding: 17755284
Market cap (USD): 397895914.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPS — annual report dated 2022-12-31
Total revenue: 2525391000
Gross profit: 129791000
Operating income: -76379000
Net income: -215384000
Capital expenditures: 53288000
Operating cash flow: -36150000
Depreciation & amortization: 122476000
Net tangible assets: -81951000
Owner earnings: -146196000
Buffett classification: The Gruesome
Stock price: 9.06
Shares outstanding: 17755284
Book value: 101192000
P/B ratio: 1.5896797478061506
Market cap (USD): 160862873.04000002
Debt to equity: 11.212220333623211
Current ratio: 1.4971850073937094
Quick ratio: 1.247420117856046
Interest coverage ratio: -0.9728073974068319
COGS to revenue (%): 94.86055822642909
SG&A to revenue (%): 7.89798490609969
Free cash flow (dilution-adjusted): -110559000
Buyback yield (%): 0
Retained earnings: -189831000
Inventory turnover: 15.185476305180151
Receivables turnover: 4.9253337494027125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.734542323023085
FCF margin (%): -4.377896333676647
Rule of 40 score: -4.377896333676647
Financial ratios for CPS — annual report dated 2023-12-31
Total revenue: 2815879000
Gross profit: 290776000
Operating income: 68231000
Net income: -201985000
Capital expenditures: 0
Operating cash flow: 117277000
Depreciation & amortization: 109931000
Net tangible assets: -262682000
Owner earnings: -92054000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.54
Shares outstanding: 17755284
Book value: -89733000
Market cap (USD): 346938249.36
Debt to equity: -13.267214959936702
Current ratio: 1.378638577068564
Quick ratio: 1.1538432099540294
Interest coverage ratio: 0.524543155208069
COGS to revenue (%): 89.67370401924231
SG&A to revenue (%): 7.66158631105953
Free cash flow (dilution-adjusted): 28816000
Buyback yield (%): 0
Retained earnings: -391816000
Inventory turnover: 17.19558585184479
Receivables turnover: 5.198264340146503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.597035739129294
FCF margin (%): 1.0233394261614226
Revenue growth (%): 11.502694038269718
Rule of 40 score: 12.52603346443114
Financial ratios for CPS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.87
Shares outstanding: 17755284
Market cap (USD): 246265789.07999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPS — annual report dated 2024-12-31
Total revenue: 2730893000
Gross profit: 302915000
Operating income: 88850000
Net income: -78130000
Capital expenditures: 4328000
Operating cash flow: 76369000
Depreciation & amortization: 103565000
Net tangible assets: -300017000
Owner earnings: 21107000
Capex to operating income (%): 4.871131119864941
Buffett classification: The Great
Stock price: 13.56
Shares outstanding: 17755284
Book value: -133370000
Market cap (USD): 240761651.04000002
Debt to equity: -8.930291669790808
Current ratio: 1.396116043642063
Quick ratio: 1.1492276991520207
Interest coverage ratio: 0.7683394010671141
COGS to revenue (%): 88.90784076856912
SG&A to revenue (%): 7.600187923876915
Free cash flow (dilution-adjusted): 16710000
Buyback yield (%): 0
Retained earnings: -470562000
Inventory turnover: 17.05028756820528
Receivables turnover: 6.254364026951388
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.684111661342128
FCF margin (%): 0.6118877597913942
Revenue growth (%): -3.0180984339170824
Rule of 40 score: -2.4062106741256883
Financial ratios for CPS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.56
Shares outstanding: 17755284
Market cap (USD): 240761651.04000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPS — quarterly report dated 2025-03-31
Total revenue: 667069000
Gross profit: 77178000
Operating income: 24375000
Net income: 1602000
Capital expenditures: 17543000
Operating cash flow: -14851000
Depreciation & amortization: 23828000
Net tangible assets: -288527000
Owner earnings: 7887000
Return on net tangible assets (%): -2.733539668731176
Capex to operating income (%): 71.97128205128205
Buffett classification: The Good
Stock price: 15.32
P/E ratio: 42.448650262172286
Shares outstanding: 17755284
Book value: -122302000
Market cap (USD): 272010950.88
Debt to equity: -9.745335317492763
Current ratio: 1.3800456120028943
Quick ratio: 1.1085757157678464
Effective tax rate (%): 62.78745644599303
Interest coverage ratio: 0.851706907998183
COGS to revenue (%): 88.4302823246171
SG&A to revenue (%): 7.674018729696629
Free cash flow (dilution-adjusted): -34593000
Buyback yield (%): 0
Retained earnings: -469010000
Inventory turnover: 3.4106222934024064
Receivables turnover: 1.3757857873548047
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0959286103068955
FCF margin (%): -5.1858203574143005
Rule of 40 score: -5.1858203574143005
Financial ratios for CPS — quarterly report dated 2025-06-30
Total revenue: 705973000
Gross profit: 93051000
Operating income: 40131000
Net income: -1401000
Capital expenditures: 7772000
Operating cash flow: -15580000
Depreciation & amortization: 24521000
Net tangible assets: -270128000
Owner earnings: 15348000
Capex to operating income (%): 19.366574468615287
Buffett classification: The Great
Stock price: 21.5
P/E ratio: 1899.1970447761194
Shares outstanding: 17755284
Book value: -105382000
Market cap (USD): 381738606
Debt to equity: -11.310394564536638
Current ratio: 1.3967477212278394
Quick ratio: 1.1107093615020809
Effective tax rate (%): 122.2911622276029
Interest coverage ratio: 1.397708275285595
COGS to revenue (%): 86.8194676000357
SG&A to revenue (%): 7.253818488809062
Free cash flow (dilution-adjusted): -26634000
Buyback yield (%): 0
Retained earnings: -470411000
Inventory turnover: 3.38037039896756
Receivables turnover: 1.4025656409930385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3842490030080525
FCF margin (%): -3.7726655268685914
Revenue growth (%): 5.832080339515103
Rule of 40 score: 2.0594148126465113
Financial ratios for CPS — quarterly report dated 2025-09-30
Total revenue: 695502000
Gross profit: 87141000
Operating income: 29999000
Net income: -7621000
Capital expenditures: 11191000
Operating cash flow: 38628000
Depreciation & amortization: 24883000
Net tangible assets: -273003000
Owner earnings: 6071000
Capex to operating income (%): 37.30457681922731
Buffett classification: The Good
Stock price: 36.93
Shares outstanding: 17755284
Book value: -110097000
Market cap (USD): 655702638.12
Debt to equity: -10.80408185509142
Current ratio: 1.3841869046660273
Quick ratio: 1.094737998140325
Interest coverage ratio: 1.0484028797092333
COGS to revenue (%): 87.47077650387777
SG&A to revenue (%): 7.964894421583259
Free cash flow (dilution-adjusted): 21287000
Buyback yield (%): 0
Retained earnings: -478055000
Inventory turnover: 3.0776753056877912
Receivables turnover: 1.3402126220495656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5450769359985137
FCF margin (%): 3.060666971482469
Revenue growth (%): -1.4832011989127063
Rule of 40 score: 1.5774657725697627
Financial ratios for CPS — annual report dated 2025-12-31
Total revenue: 2740915000
Gross profit: 327524000
Operating income: 106854000
Net income: -4165000
Capital expenditures: 0
Operating cash flow: 64442000
Depreciation & amortization: 97975000
Net tangible assets: -253162000
Owner earnings: 93810000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 32.83
Shares outstanding: 17755284
Book value: -91577000
Market cap (USD): 582905973.72
Debt to equity: -13.025344791814538
Current ratio: 1.2987970170858656
Quick ratio: 1.0715126983167673
Interest coverage ratio: 0.9317904356622135
COGS to revenue (%): 88.05055975832889
SG&A to revenue (%): 7.820964896758929
Free cash flow (dilution-adjusted): 1002000
Buyback yield (%): 0
Retained earnings: -474727000
Inventory turnover: 15.652160659969258
Receivables turnover: 5.889235535902675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.253215122919837
FCF margin (%): 0.036557135117287476
Revenue growth (%): 0.36698618364029645
Rule of 40 score: 0.4035433187575839
Financial ratios for CPS — quarterly report dated 2025-12-31
Total revenue: 731492000
Gross profit: 70154000
Operating income: 12349000
Net income: 3328000
Capital expenditures: 11686000
Operating cash flow: 56245000
Depreciation & amortization: 24743000
Net tangible assets: -253162000
Owner earnings: 16385000
Return on net tangible assets (%): -6.4721403686177235
Capex to operating income (%): 94.63114422220423
Buffett classification: The Gruesome
Stock price: 32.83
P/E ratio: 43.788008843149036
Shares outstanding: 17755284
Book value: -91577000
Market cap (USD): 582905973.72
Debt to equity: -13.025344791814538
Current ratio: 1.2987970170858656
Quick ratio: 1.0715126983167673
Interest coverage ratio: 0.42981448609515854
COGS to revenue (%): 82.32721615547402
SG&A to revenue (%): 7.733372340367358
Free cash flow (dilution-adjusted): 40942000
Buyback yield (%): 0
Retained earnings: -474727000
Inventory turnover: 3.9057066327688745
Receivables turnover: 1.571711884764219
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.069383958980825
FCF margin (%): 5.59705369300006
Revenue growth (%): 5.174679583955187
Rule of 40 score: 10.771733276955246
Financial ratios for CRON — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.92
Shares outstanding: 373662039
Market cap (USD): 1464755192.8799999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRON — annual report dated 2022-12-31
Total revenue: 80368382.35294117
Gross profit: 11350000
Operating income: -76757352.94117646
Net income: -124069117.64705881
Capital expenditures: 2537500
Operating cash flow: -65402941.176470585
Depreciation & amortization: 9648529.411764706
Net tangible assets: 820697058.8235294
Owner earnings: -116958088.2352941
Return on net tangible assets (%): -14.251067062790955
Buffett classification: The Gruesome
Stock price: 2.54
Shares outstanding: 373662039
Book value: 838944117.6470588
P/B ratio: 1.131304885624437
Market cap (USD): 949101579.0600001
Debt to equity: 0.003397127341441097
Current ratio: 14.095895237535968
Quick ratio: 13.544497621704153
Interest coverage ratio: -8029.999999999999
COGS to revenue (%): 65.24459977493345
R&D to revenue (%): 12.013613782124592
SG&A to revenue (%): 92.15652189824429
Free cash flow (dilution-adjusted): -80216911.76470587
Buyback yield (%): 0
Retained earnings: 360795588.2352941
Inventory turnover: 1.8986927234484412
Receivables turnover: 2.893857558909187
Capitalized R&D asset: 9655147.05882353
ROCI (R&D-adjusted, %): -8.258550772695555
FCF margin (%): -99.81152962918911
Rule of 40 score: -99.81152962918911
Financial ratios for CRON — annual report dated 2023-12-31
Total revenue: 91113636.36363636
Gross profit: 9021969.696969697
Operating income: -60537878.78787878
Net income: -56032575.75757576
Capital expenditures: 1897727.2727272727
Operating cash flow: -32450757.575757574
Depreciation & amortization: 6143939.393939394
Net tangible assets: 816239393.9393939
Owner earnings: -51786363.63636364
Return on net tangible assets (%): -6.34450677348817
Buffett classification: The Gruesome
Stock price: 2.09
Shares outstanding: 373662039
Book value: 830396969.6969696
P/B ratio: 0.9404582266177914
Market cap (USD): 780953661.51
Debt to equity: 0.002329116048914174
Current ratio: 22.544167733520137
Quick ratio: 21.807555738061307
COGS to revenue (%): 62.63573626008149
R&D to revenue (%): 4.858235636484577
SG&A to revenue (%): 67.29192649871123
Free cash flow (dilution-adjusted): -41687121.21212121
Buyback yield (%): 0
Retained earnings: 315696212.1212121
Inventory turnover: 2.470306607640597
Receivables turnover: 3.35219354479068
Capitalized R&D asset: 10895463.680926915
ROCI (R&D-adjusted, %): -7.209791385676789
Rosenberg metric: -0.24111805743060025
FCF margin (%): -45.75288933233558
Revenue growth (%): 13.370001605241907
Rule of 40 score: -32.382887727093674
Financial ratios for CRON — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.19
Shares outstanding: 373662039
Market cap (USD): 818319865.41
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRON — annual report dated 2024-12-31
Total revenue: 113161538.46153846
Gross profit: 17620979.02097902
Operating income: -41642657.34265734
Net income: 28727272.72727273
Capital expenditures: 8679020.97902098
Operating cash flow: 13176923.076923078
Depreciation & amortization: 6528671.328671329
Net tangible assets: 691855244.7552447
Owner earnings: 26576923.076923076
Return on net tangible assets (%): 3.8413993791902383
Buffett classification: The Gruesome
Stock price: 2.02
P/E ratio: 26.274590210696196
Shares outstanding: 373662039
Book value: 776910489.5104896
P/B ratio: 0.9715370418741256
Market cap (USD): 754797318.78
Debt to equity: 0.0018164110669659814
Current ratio: 18.835271629778674
Quick ratio: 18.168289738430584
Effective tax rate (%): -9.391570546110534
COGS to revenue (%): 57.11063459007174
R&D to revenue (%): 2.613381452345493
SG&A to revenue (%): 47.47035304441327
Free cash flow (dilution-adjusted): -2105594.4055944053
Buyback yield (%): 0
Retained earnings: 320076223.7762238
Inventory turnover: 2.7879272376240607
Receivables turnover: 5.435707087672153
Capitalized R&D asset: 9109306.338269573
ROCI (R&D-adjusted, %): -5.6161273215263385
Rosenberg metric: 1.942613778485762
FCF margin (%): -1.8606979316652346
Revenue growth (%): 24.198246253621665
Rule of 40 score: 22.33754832195643
Financial ratios for CRON — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.02
Shares outstanding: 373662039
Market cap (USD): 754797318.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRON — quarterly report dated 2025-03-31
Total revenue: 29299300.6993007
Gross profit: 9604195.804195805
Operating income: -2459440.5594405597
Net income: 5400699.300699301
Capital expenditures: 10669930.069930071
Operating cash flow: -1465734.2657342658
Depreciation & amortization: 1986013.9860139862
Net tangible assets: 694062937.0629371
Owner earnings: -3283216.783216784
Return on net tangible assets (%): -0.4730430927648084
Buffett classification: The Gruesome
Stock price: 1.81
P/E ratio: 31.30744061710799
Shares outstanding: 373662039
Book value: 779555944.0559441
P/B ratio: 0.8675814683307244
Market cap (USD): 676328290.59
Debt to equity: 0.0016299399424990917
Current ratio: 27.795358266763497
Quick ratio: 26.748305495037524
Effective tax rate (%): -6.260319207484864
COGS to revenue (%): 44.22168122583417
R&D to revenue (%): 1.892691775263736
SG&A to revenue (%): 38.097283879898804
Free cash flow (dilution-adjusted): -13664335.664335664
Buyback yield (%): 0
Retained earnings: 324346853.14685315
Inventory turnover: 0.5354449036210732
Receivables turnover: 1.3193311710803917
Capitalized R&D asset: 554545.4545454546
ROCI (R&D-adjusted, %): -0.26644150650456083
FCF margin (%): -46.637070981908444
Rule of 40 score: -46.637070981908444
Financial ratios for CRON — quarterly report dated 2025-06-30
Total revenue: 32300729.927007295
Gross profit: 10586861.313868612
Operating income: -3325547.445255474
Net income: -28089051.09489051
Capital expenditures: 2800729.927007299
Operating cash flow: 2056934.306569343
Depreciation & amortization: 3067153.2846715325
Net tangible assets: 733435766.4233576
Owner earnings: -27822627.737226274
Return on net tangible assets (%): -3.7934648146360446
Buffett classification: The Gruesome
Stock price: 1.91
Shares outstanding: 373662039
Book value: 824967883.2116787
P/B ratio: 0.8651179143017291
Market cap (USD): 713694494.49
Debt to equity: 0.001779321645788467
Current ratio: 24.650297777305116
Quick ratio: 23.529857492289697
COGS to revenue (%): 42.82518304257435
R&D to revenue (%): 2.0993401428184035
SG&A to revenue (%): 39.01292596944771
Free cash flow (dilution-adjusted): -1752554.7445255474
Buyback yield (%): 0.36941525690890764
Retained earnings: 309547445.25547445
Inventory turnover: 0.44969389207916094
Receivables turnover: 1.1238317757009344
Capitalized R&D asset: 1049647.6443264764
ROCI (R&D-adjusted, %): -0.3678414461287439
Rosenberg metric: 1.772019771541128
FCF margin (%): -5.425743469221731
Revenue growth (%): 10.244030253521487
Rule of 40 score: 4.818286784299756
Financial ratios for CRON — quarterly report dated 2025-09-30
Total revenue: 35128057.55395684
Gross profit: 13188489.208633095
Operating income: -3615827.3381294967
Net income: 20374820.143884894
Capital expenditures: 3225179.8561151084
Operating cash flow: 9574820.143884894
Depreciation & amortization: 2541007.1942446046
Net tangible assets: 724648920.8633094
Owner earnings: 19690647.482014388
Return on net tangible assets (%): 2.717267205553272
Buffett classification: The Gruesome
Stock price: 2.78
P/E ratio: 12.745885130325552
Shares outstanding: 373662039
Book value: 814423741.0071943
P/B ratio: 1.2754791100948808
Market cap (USD): 1038780468.42
Debt to equity: 0.0015388026490019424
Current ratio: 22.454793386417318
Quick ratio: 21.281905179341077
Effective tax rate (%): -4.873171634882429
COGS to revenue (%): 36.878430408781846
R&D to revenue (%): 2.754567051691652
SG&A to revenue (%): 34.58671254198411
Free cash flow (dilution-adjusted): 4595683.453237411
Buyback yield (%): 0.12874809573351587
Retained earnings: 323764028.77697843
Inventory turnover: 0.37384516370128923
Receivables turnover: 1.2791574976422508
Capitalized R&D asset: 1604954.3664338603
ROCI (R&D-adjusted, %): -0.4124752357528314
Rosenberg metric: 3.836631018113393
FCF margin (%): 13.08265749160318
Revenue growth (%): 8.753138499775993
Rule of 40 score: 21.83579599137917
Financial ratios for CRON — quarterly report dated 2025-12-31
Total revenue: 42616788.32116788
Gross profit: 11816788.321167883
Operating income: -4670072.9927007295
Net income: -358394.16058394156
Capital expenditures: 1561313.8686131386
Operating cash flow: 8638686.131386861
Depreciation & amortization: 2669343.0656934306
Net tangible assets: 743451824.8175182
Owner earnings: 749635.0364963503
Buffett classification: The Gruesome
Stock price: 2.63
Shares outstanding: 373662039
Book value: 834276642.3357663
P/B ratio: 1.1779439968720664
Market cap (USD): 982731162.5699999
Debt to equity: 0.0013202573320652798
Current ratio: 19.592130657646255
Quick ratio: 18.621951978749458
COGS to revenue (%): 48.54329022865463
R&D to revenue (%): 2.3670463303930807
SG&A to revenue (%): 35.45259912648797
Free cash flow (dilution-adjusted): 6067883.211678831
Buyback yield (%): 0.31715574308409844
Retained earnings: 326829197.0802919
Inventory turnover: 0.6062459893048128
Receivables turnover: 1.0207524738627225
Capitalized R&D asset: 1880842.199233314
ROCI (R&D-adjusted, %): -0.540864515807363
Rosenberg metric: -1.417594225707543
FCF margin (%): 14.238246124860837
Revenue growth (%): 21.318374224673033
Rule of 40 score: 35.55662034953387